Read more about the article Biogen Beats Expectations, Hikes Outlook as Alzheimer’s drug Leqembi and other new Products Gain Traction
Citation: Image used for information purpose only. Picture Credit: https://www.reuters.com/

Biogen Beats Expectations, Hikes Outlook as Alzheimer’s drug Leqembi and other new Products Gain Traction

Biogen reported strong second-quarter earnings and revenue on Thursday, surpassing market expectations and prompting the company to raise its full-year guidance. The biotech firm's cost-cutting measures have begun to show…

Continue ReadingBiogen Beats Expectations, Hikes Outlook as Alzheimer’s drug Leqembi and other new Products Gain Traction
Read more about the article Bristol Myers Squibb Exceeds Earnings Forecasts, Alters Outlook as Cost-Cutting Measures Take Effect
Citation: Image used for information purpose only. Picture Credit: https://www.reuters.com/

Bristol Myers Squibb Exceeds Earnings Forecasts, Alters Outlook as Cost-Cutting Measures Take Effect

On Friday, Bristol Myers Squibb announced second-quarter earnings and revenue that exceeded expectations, subsequently raising its full-year guidance as the company implements significant cost-reduction strategies.  The pharmaceutical leader adjusted its…

Continue ReadingBristol Myers Squibb Exceeds Earnings Forecasts, Alters Outlook as Cost-Cutting Measures Take Effect

Mental Health Practitioners Delve into the Realm of AI-Driven Digital Therapeutics to Enhance Patient Treatment and Elevate Healthcare

A novel method of providing individualized mental health care is being made possible by the combination of human creativity and artificial intelligence. Clinicians and behavioral health care facilities can treat…

Continue ReadingMental Health Practitioners Delve into the Realm of AI-Driven Digital Therapeutics to Enhance Patient Treatment and Elevate Healthcare